Carbapenemase-producing Enterobacteriaceae isolated in Arad Clinical Emergency Hospital in 2021

Article Sidebar

PDF
Published: Jun 30, 2022
DOI: https://doi.org/10.70921/medev.v28i2.1078
Keywords:
Carbapenemase-producing Enterobacteriaceae, β-lactamases, AmpC, Metallo-β-lactamases (MBLs), Innovation, technology, research projects, etc

Main Article Content

I. Toma
Department XIV – microbiology, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy Timisoara
I. Olariu
Department of Dentistry, Faculty of Dentistry, Faculty of Medicine, Vasile Goldis Western University of Arad; Arad County Emergency Clinical Hospital
T. Olariu
Department of general medicine, Faculty of Medicine, Vasile Goldis Western University of Arad; Arad County Emergency Clinical Hospital
C. Precup
Anatomy and Forensic Medicine Department, Faculty of Medicine Vasile Goldis Western University of Arad; Arad County Emergency Clinical Hospital
L.R. Bran
Arad College of Nursing
V. Toma
Department of training in residence and postgraduate courses, Faculty of Medicine Vasile Goldis Western University of Arad
M.F. Sandor
Anatomy and Forensic Medicine Department, Faculty of Medicine Vasile Goldis Western University of Arad
S. Talpes
Arad County Emergency Clinical Hospital
D.G. Negru
Epidemiology Private Practice dr. Negru Dana

Abstract

Knowing hospital circulation of antimicrobial - resistant bacteria is a must in present time, when “superbugs” are present in higher prevalence, in medical facilities and in community as well. In 2021, a pandemic year, hospitals were mainly dedicated to Covid 19 patients, with reduced activity for general population. Even so, data shows that Gram negative bacteria (GNB), multidrog resistant (MDR) and bacteria displaying carbapenemase-production are all higher at an alarming level. Our study demonstrate that MDR strains reached 52.67% for GNB and carbapemenase-producing Enterobacteriaceae were present in 24.24% for ESBLs, 10.05% for oxallicinases, 7.13% for KPC activity, 6.16% for OXA 48, 4.54% for MBLs and 1.70% for AmpC.

Article Details

Issue
Vol. 28 No. 2 (2022): Volume XXVIII, No. 2/2022
Section
Articles